Best Final Expense Insurance for People With Diabetes

Research Snapshot

• Topic: Best final expense insurance for people with diabetes (permanent whole life, approximately $15,000–$25,000).
• Target buyer: A senior with diabetes who wants a carrier whose underwriting may be reasonably favorable for well-managed or otherwise insurable diabetes, while understanding that eligibility and rates depend on diabetes type, control, complications, medications, age, and other health factors.
• Platforms included (7): openai, anthropic, deepseek, grok, perplexity, kimi, google.
• Research date: 2026-09-22 (authoritative run date). Platform-reported dates are provenance metadata and do not independently prove freshness.
• Unique entities named: 20.
• Qualifying entities: 10.
• Eligibility rule: Named by at least two platforms during ranking discovery.
• Ranking unit: Life insurance carrier.
• Geography: United States.

The Consensus Ranking

Questions This Section Answers

• What are the best final expense insurance carriers for a senior with diabetes seeking $15,000 to $25,000 of permanent coverage in 2026?
• Which final expense carrier for people with diabetes was named by the most AI platforms, and how many platforms named it?

The table below is the supplied final ranking, ordered by platform mentions, then average listed rank, then best listed rank. Platform mentions count only ranking-discovery mentions; they do not reflect how many platforms later completed a fit assessment.

Which Option Is Best for Which Version of the Buyer Need?

Questions This Section Answers

• Which final expense carrier should a buyer with diabetes choose if they need guaranteed acceptance rather than health-question underwriting?
• Is Mutual of Omaha or Transamerica better for a senior with insulin-dependent diabetes seeking $15,000 to $25,000 of final expense coverage?
• Which final expense carrier for people with diabetes is best if the applicant has diabetic neuropathy and wants first-day level coverage?

1. Mutual of Omaha

Questions This Section Answers

• Is Mutual of Omaha worth it for a senior with diabetes seeking $15,000 to $25,000 of final expense coverage, and what are its main drawbacks?
• Which final expense carrier should a buyer with diabetes choose if their diabetes was diagnosed before age 50?

Verdict. Mutual of Omaha is the consensus leader and a good — not automatic — fit. Its Living Promise Whole Life product is purpose-built for final expenses, offers $2,000–$40,000 (Level) and $2,000–$20,000 (Graded) coverage for ages 45–85, requires no medical exam, and uses 5–7 yes/no health questions plus MIB and pharmacy checks ^[1]. For a well-controlled type 2 diabetic diagnosed at age 50 or older, platforms describe Level Benefit as attainable with day-one full coverage ^[4]. The catch is strictness: platforms repeatedly call Mutual of Omaha the strictest simplified-issue underwriter among the ranked carriers, with diabetes diagnosed before age 45–50, diabetic neuropathy, retinopathy, nephropathy, amputation, or recent diabetes hospitalization pushing applicants to Graded or decline ^[6].

Why it ranked here. It is the only entity named by all 7 platforms, with an average listed position of 1.86 and four platforms placing it first ^[9]. No other carrier achieved 100% platform share.

Best suited for. Applicants approximately ages 45–85 seeking $15,000–$25,000 of permanent final-expense coverage; people with diabetes who can answer the simplified-underwriting health questions acceptably; applicants who prioritize fixed premiums, lifetime coverage, and no medical exam ^[11].

Main strengths for this use case. The Level Benefit face-amount range directly accommodates $15,000–$25,000; simplified underwriting without a medical exam may be practical for some applicants with diabetes; Guaranteed Whole Life offers a fallback when health history prevents acceptance for a simplified-issue plan; permanent coverage and fixed-premium positioning are consistent with final-expense planning ^[11]. Platforms also cite A+ (Superior) financial strength and fast claims processing ^[13]. .

2. Transamerica

Questions This Section Answers

• Is Transamerica worth it for a senior with insulin-dependent diabetes seeking $15,000 to $25,000 of final expense coverage, and what are its main drawbacks?
• Which final expense carrier for people with diabetes should a buyer choose if they have diabetes paired with COPD or heart disease?

Verdict. Transamerica is the strongest alternative for applicants Mutual of Omaha would grade or decline. Platforms describe notably lenient diabetes underwriting — insulin-dependent diabetes without complications, type 2 on medication, and diabetes paired with COPD or heart disease can qualify for day-one Level coverage where competitors decline or grade ^[15]. Immediate Solution and 10-Pay Solution provide day-one full death benefits with level premiums to age 121 or a 10-year payment period ^[17]. The tradeoffs are higher premiums than Mutual of Omaha for equivalent applicants and a materially worse customer-service record ^[18].

Why it ranked here. Named by 6 of 7 platforms (85.7%), average listed position 2.17, with one platform placing it first ^[20].

Best suited for. Applicants seeking $15,000–$25,000 of permanent whole-life coverage with a day-one death benefit; applicants who prefer level premiums to age 121 or a 10-year premium-payment period; applicants with diabetes who may qualify for simplified underwriting but are not seeking guaranteed issue ^[20].

Main strengths for this use case. Coverage range directly matches the requested $15,000–$25,000 target for many senior age bands; Immediate Solution and 10-Pay Solution offer permanent whole-life coverage with a day-one full death benefit; simplified, potentially nonmedical underwriting may be convenient for some applicants with well-managed diabetes; 10-Pay Solution can limit premium payments to 10 years if the applicant qualifies ^[17]. Platforms also report real-time underwriting decisions in as fast as 10–15 minutes for FE Express Solution ^[22].

Main limitations. Simplified issue is not guaranteed issue; diabetes or related complications may lead to declination, higher premiums, modified terms, or additional requirements. At ages 76–85, the maximum for Immediate Solution and 10-Pay Solution is $25,000, leaving little room above the requested range. Easy Solution's graded benefit can be materially unsuitable when immediate full protection is required. Product, rider, and underwriting availability varies by state ^[24]. Platforms also report a NAIC complaint index of 3.86, nearly four times the industry average, and a J.D.

3. Royal Neighbors of America

Questions This Section Answers

• Is Royal Neighbors of America worth it for a senior with diabetic neuropathy seeking $15,000 to $25,000 of final expense coverage, and what are its main drawbacks?
• Which final expense carrier for people with diabetes should a buyer choose if they started insulin before age 30?

Verdict. Royal Neighbors of America is the most polarized entity in the ranking and the standout for specific diabetes complications. Platforms report that diabetic neuropathy is not asked on the application, that no height/weight build chart is used, and that applicants who began insulin at age 30 or later can qualify for Level (first-day full) coverage ^[25]. The counterweight is that one platform could not verify any diabetes-specific underwriting, published rates, or third-party evaluations and rated the fit "uncertain" ^[28].

Why it ranked here. Named by 6 of 7 platforms (85.7%) but with an average listed position of 6.33 — the widest spread in the ranking, from first place on one platform to tenth on another ^[27].

Best suited for. Applicants ages 50–85 seeking approximately $15,000–$25,000 of permanent coverage; applicants with no-insulin diabetes who want a level death benefit; some insulin-using applicants without kidney disease, neuropathy, or other diabetes complications ^[31].

Main strengths for this use case. Diabetes without insulin is explicitly shown as acceptable even for the Preferred category in the cited underwriting chart; insulin use without listed complications may still qualify for the Standard SIWL category; the requested $15,000–$25,000 range is within the face amounts stated in the current agent guide; level death benefit and guaranteed level premiums are available through SIWL; simplified issue may avoid a traditional medical exam ^[31]. Platforms also cite a $30–$50 annual certificate fee and competitive pricing at ages 60–80 ^[34].

Main limitations. The underwriting guide is an agent-use document and does not guarantee an individual offer; diabetes complications may move an applicant from level-benefit SIWL to graded or guaranteed issue; the product guide and older rate guide report different SIWL maximums ($25,000 vs. $30,000 vs.

4. AIG

Questions This Section Answers

• Is AIG (Corebridge) worth it for a senior with diabetes who cannot answer health questions, and what are its main drawbacks?
• Which final expense carrier for people with diabetes should a buyer choose if they need guaranteed acceptance up to $25,000?

Verdict. AIG — whose relevant U.S. life business now operates as Corebridge Financial — is a mixed fit that serves two distinct roles. Its Guaranteed Issue Whole Life product removes diabetes-related knockout questions entirely, guaranteeing acceptance for ages 50–80 with no medical exam or health questions, up to $25,000 ^[35]. Its SimpliNow Legacy simplified-issue path applies condition-specific underwriting: platforms report A1C ≤8.6% qualifies for Level (no grading period) if not on insulin, A1C 8.7–9.9 results in Graded, and A1C ≥10 or diabetic amputation results in automatic decline ^[37]. The guaranteed-issue route carries a two-year graded period paying 110% of premiums for non-accidental death ^[38].

Why it ranked here. Named by 5 of 7 platforms (71.4%), average listed position 5.40, best position 3 ^[39].

Best suited for. Applicants who want permanent whole-life coverage without a medical exam; people with diabetes who are willing to complete health questions for possible simplified underwriting; applicants who need final-expense coverage and can accept a graded or limited early death benefit if Guaranteed Issue is selected ^[41].

Main strengths for this use case. Relevant permanent final-expense product family; simplified-issue pathway may be accessible to some applicants with diabetes without a medical exam; Guaranteed Issue fallback may be available when health underwriting prevents simplified issue; potentially appropriate coverage purpose for funeral and other end-of-life bills ^[41]. Platforms also report instant automated underwriting decisions within minutes, no tele-interviews, and no APS required on the simplified-issue path ^[42].

Main limitations. No verified public evidence establishes favorable diabetes underwriting on the simplified-issue path; no public price table was found for the requested coverage range; Guaranteed Issue and simplified-issue versions may have a two-year limited benefit; the requested $15,000–$25,000 amount, issue ages, state availability, and product eligibility require verification; the AIG name may cause confusion because the relevant direct-to-consumer business is now branded Corebridge Direct and the issuer may be American General Life Insurance Company ^[41].

5. Gerber Life Guaranteed Life Insurance

Questions This Section Answers

• Is Gerber Life Guaranteed Life Insurance worth it for a senior with diabetes who has been declined elsewhere, and what are its main drawbacks?
• Which final expense carrier for people with diabetes has the lowest published cost for guaranteed acceptance, and what fees apply?

Verdict. Gerber Life Guaranteed Life Insurance is the clearest guaranteed-acceptance option in the ranking and a good — not strong — fit for this buyer. It accepts all applicants ages 50–80 (50–75 in New York) regardless of health, with no medical exam or health questions, and offers $5,000–$25,000 of permanent whole-life coverage [e5:official:C1]. The tradeoff is structural: for non-accidental death in the first two years, the benefit is 110% of earned premiums rather than the full face amount, and guaranteed-issue pricing is generally higher than underwritten alternatives ^[44].

Why it ranked here. Named by 5 of 7 platforms (71.4%), average listed position 7.60, best position 4 ^[44].

Best suited for. Applicants ages 50–80, or 50–75 in New York, who need guaranteed acceptance; applicants with diabetes or other health conditions who prioritize approval certainty over lowest premium; buyers seeking $15,000–$25,000 of permanent coverage for funeral, burial, or related final expenses ^[44][e5:official:C1].

Main strengths for this use case. Guaranteed acceptance can eliminate diabetes-related declination risk; the $15,000–$25,000 range directly fits the stated target, subject to state limits; permanent whole-life coverage and level premiums can support predictable final-expense planning; no medical exam or lengthy health questionnaire is required ^[44][e5:official:C1]. Accidental death is covered at the full face amount from day one ^[47].

Main limitations. The first two years generally provide only 110% of earned premiums for nonaccidental death, which can leave beneficiaries far below the selected $15,000–$25,000 amount; guaranteed-issue pricing may be materially higher than pricing available to a senior with well-managed, insurable diabetes through simplified or fully underwritten coverage; coverage is capped at $25,000 overall and $15,000 in South Dakota; the product is unavailable in Montana and has a lower maximum issue age in New York; published sample premiums differ across official Gerber materials ^[44][e5:official:C1]^[48].

Pricing or cost summary. Gerber publishes sample monthly premiums rather than a buyer-specific guaranteed quote.

6. Aetna

Questions This Section Answers

• Is Aetna (Accendo) worth it for a senior with insulin-dependent diabetes seeking $15,000 to $25,000 of final expense coverage, and what are its main drawbacks?
• Which final expense carrier for people with diabetes should a buyer choose if they need coverage at ages 80 to 89?

Verdict. Aetna, through its Accendo Final Expense Whole Life product, is a good fit with the highest best-position in the ranking outside the top two: one platform placed it first ^[49]. Platforms report that insulin is not mentioned on the application, diabetes diagnosed at any age is acceptable, and issue ages reach 89 ^[50]. The counterweight is that Aetna does not appear to offer a guaranteed-issue fallback, and applicants with diabetic complications such as neuropathy, retinopathy, nephropathy, insulin shock, or diabetic coma may be downgraded or declined ^[52].

Why it ranked here. Named by 4 of 7 platforms (57.1%) but with an average listed position of 2.75 — the second-best average in the ranking after Mutual of Omaha ^[49].

Best suited for. Applicants with stable or otherwise insurable diabetes who want permanent whole life coverage without a medical exam; applicants seeking $15,000–$25,000, which is within the published Accendo face-amount range for many ages; applicants who may need a Modified benefit option because of diabetes complications or other disclosed health conditions; older applicants who value simplified application processing and potentially immediate underwriting feedback ^[55].

Main strengths for this use case. Permanent whole life structure appropriate for a final-expense objective; $15,000–$25,000 is generally within the advertised face-amount range, subject to age and state limits; simplified issue can avoid a traditional medical exam while still allowing health-based underwriting; Modified coverage may provide an alternative to outright decline for some less favorable health profiles; issue ages extending to approximately 89 may help older applicants ^[55]. Platforms also report a 10% premium discount when paired with an Aetna Medicare Supplement policy ^[56].

Main limitations. Diabetes acceptance is not guaranteed and is not determined solely by the diagnosis; complications, medication history, insulin use, disease duration, and other conditions may materially affect the result. Aetna's public materials do not provide a sufficiently current, complete diabetes underwriting table for consumers. Prescription-drug and MIB reviews can affect eligibility even when the applicant believes the diabetes is controlled.

7. Aflac

Questions This Section Answers

• Is Aflac worth it for a senior with diabetes seeking $15,000 to $25,000 of final expense coverage, and what are its main drawbacks?
• Which final expense carrier for people with diabetes should a buyer choose if they are overweight and worried about a height/weight build chart?

Verdict. Aflac is a good, middle-ground fit with one distinctive underwriting feature: platforms report no height-to-weight build chart on the final expense application, which is favorable for diabetic seniors who carry extra weight ^[57]. Platforms also report that both type 1 and type 2 diabetics, including insulin users, can qualify for immediate day-one Level coverage provided there are no severe complications such as neuropathy, retinopathy, nephropathy, amputation, or a diabetic coma/shock within two years ^[58]. The tradeoffs are mid-tier pricing, a $48 annual administrative fee, and no guaranteed-issue option ^[60].

Why it ranked here. Named by 4 of 7 platforms (57.1%) with an average listed position of 3.00 and a best position of 2 — the best average among the four-mention group ^[62].

Best suited for. Applicants age 45 to 75 seeking $15,000 to $25,000 who can qualify for the Level Plan or who prioritize simplified underwriting over potentially lower fully underwritten premiums; applicants who need permanent coverage with fixed premiums, cash value, and a relatively quick application process without a physical exam; applicants in states where Aflac Final Expense policies are available and who are comfortable obtaining an individualized quote through an agent ^[64].

Main strengths for this use case. The requested $15,000 to $25,000 benefit generally falls within Aflac's published Final Expense Whole Life ranges; the Level Plan is designed to pay the full face amount for natural and accidental death from issue, if approved and subject to policy terms; a health questionnaire without a physical exam may be practical for some applicants with diabetes; the product is permanent, uses level premiums, and may accumulate cash value; Aflac expressly discusses final-expense and simplified-issue options for applicants with diabetes ^[64]. Platforms also report an AM Best A+ rating and a three-tier structure (Preferred, Standard, Modified) ^[68]. .

8. American Amicable

Questions This Section Answers

• Is American Amicable worth it for a senior with type 2 diabetes diagnosed after age 50 who wants immediate day-one coverage, and what are its main drawbacks?
• Which final expense carrier for people with diabetes should a buyer choose if they started insulin before age 50?

Verdict. American Amicable is the most internally contested entity in the ranking: two platforms rated it "strong" and two rated it "mixed," with the disagreement centered on how lenient its diabetes underwriting actually is. Its Senior Choice product offers Immediate Death Benefit, Graded Death Benefit, and Return of Premium variants, with issue ages 50–85 and face amounts that accommodate $15,000–$25,000 ^[70]. Platforms report that type 2 diabetics diagnosed after age 50 and controlled with oral medication may qualify for the Immediate plan, while insulin-dependent diabetes or diagnosis before age 50 typically requires the graded or ROP plan ^[72]. Company underwriting guidelines cited by one platform state that diabetes diagnosed, treated, or medicated prior to age 35 is ineligible, as is insulin use or tobacco use within the past 12 months, or diabetes combined with overweight, gout, retinopathy, or protein in the urine ^[74].

Why it ranked here. Named by 4 of 7 platforms (57.1%), average listed position 5.50, best position 3 ^[77].

Best suited for. Ages approximately 50–80 or 50–85, depending on state and product edition, seeking simplified-issue permanent final-expense coverage; applicants with type 2 diabetes diagnosed later in life, no major diabetic complications, and no current insulin use, subject to current underwriting; applicants who may qualify for the Immediate Death Benefit and want full face amount from policy issue rather than a graded benefit ^[70].

Main strengths for this use case. Purpose-built senior final-expense whole life product; target coverage range is within publicly described Senior Choice face-amount bands for many ages; simplified underwriting may avoid a routine full medical-exam process, although interviews, database checks, or additional requirements may occur; multiple benefit structures may give an eligible diabetic applicant a choice between immediate coverage and more permissive graded alternatives ^[70]. Platforms also report that accidental death is covered at 100% from day one, even on graded and ROP plans ^[80]. .

9. Trinity Life Insurance Company

Questions This Section Answers

• Is Trinity Life Insurance Company worth it for a senior with diabetes seeking $15,000 to $25,000 of final expense coverage, and what are its main drawbacks?
• Which final expense carrier for people with diabetes should a buyer choose if they started insulin after age 40 and want first-day level coverage?

Verdict. Trinity Life Insurance Company is the most methodologically problematic entity in the ranking because the supplied official website resolves to a church, not an insurer, and platforms split sharply on whether the carrier is verifiable at all. Three platforms rated the fit "good" and described a Golden Eagle Final Expense product with explicit diabetes acceptance — insulin started after age 40, diabetic neuropathy, and a two-year look-back on cardiac and cancer events ^[81]. Three platforms rated it "uncertain" or "weak," noting that the official website is a church site, that no independent source confirms Trinity Life as a licensed final expense insurer, and that the insurer's product information was found at a different domain ^[83].

Why it ranked here. Named by 3 of 7 platforms (42.9%), average listed position 7.33, best position 6 ^[86].

Best suited for. Applicants generally ages 50–85 seeking approximately $15,000–$25,000 of permanent coverage; applicants with diabetes who may qualify through simplified underwriting and are willing to accept a possible graded-benefit outcome; buyers prioritizing level premiums, permanent coverage, and no medical exam over guaranteed acceptance ^[87].

Main strengths for this use case. Simplified-issue whole life offers a plausible path for some applicants with diabetes without a traditional medical exam; the simplified-issue face amount reaches $25,000, matching the upper end of the target; permanent coverage, level premiums, and a guaranteed death benefit are aligned with final-expense planning ^[87]. Platforms also report explicit acceptance of insulin started after age 40 and diabetic neuropathy for Level coverage, plus a built-in Accelerated Living Benefit rider at no extra cost ^[81]. .

10. Foresters Financial

Questions This Section Answers

• Is Foresters Financial worth it for a senior with diabetes seeking $15,000 to $25,000 of final expense coverage, and what are its main drawbacks?
• Which final expense carrier for people with diabetes should a buyer choose if they want no bloodwork or paramedical exam and a fraternal member structure?

Verdict. Foresters Financial is the lowest-mention qualifier in the ranking and a good-but-not-definitive fit. Its PlanRight Whole Life product offers simplified-issue coverage from $5,000 to $35,000 for ages 50–85, with no bloodwork, saliva swab, or paramedical exam ^[89]. Platforms report that insulin use and the age of diabetes diagnosis are not health considerations for coverage, and that diabetic neuropathy is accepted only as modified coverage ^[90]. The main structural limitation is that PlanRight Standard generally caps coverage at $20,000, so reaching $25,000 may require Preferred eligibility ^[89].

Why it ranked here. Named by only 2 of 7 platforms (28.6%) — the minimum for qualification — but with an average listed position of 5.00 and a best position of 2, the best average among the bottom four entities ^[89].

Best suited for. Applicants ages 50 through 85 seeking permanent final-expense coverage from $15,000 to $20,000 under PlanRight Standard or potentially up to $35,000 under PlanRight Preferred, subject to age and underwriting limits; applicants with diabetes who prefer no bloodwork, saliva swab, or paramedical exam and are willing to complete medical questions and underwriting searches; applicants seeking immediate full face-value death benefit eligibility through Preferred or Standard rather than a two-year graded benefit ^[89].

Main strengths for this use case. Permanent final-expense coverage with level premiums and protection to age 121; simplified-issue process without routine bloodwork, saliva collection, or paramedical examination; Preferred and Standard can provide the full face amount from issue, which is more suitable than a graded plan when immediate final-expense protection matters; coverage limits can accommodate $15,000 to $20,000 for many applicants ages 50 through 80 and potentially $25,000 under Preferred ^[89]. Platforms also report an A.M. Best rating of A (Excellent) affirmed for 27 consecutive years, and fraternal member benefits including discounted diabetes medications through an Accu-Chek partnership ^[95]. .

What the Cross-Platform Study Reveals About This Market

Questions This Section Answers

• What does the cross-platform AI study reveal about how final expense carriers treat diabetes underwriting in 2026?
• Which final expense carriers for people with diabetes appear across the most AI platform recommendations, and what does that pattern suggest?

Three patterns dominate the cross-platform evidence.

First, underwriting strictness and rate competitiveness trade off directly. Mutual of Omaha is named by all 7 platforms and is repeatedly described as offering the lowest or near-lowest simplified-issue rates for qualifying diabetics, but it is also repeatedly described as the strictest underwriter among the ranked carriers ^[97]. Transamerica is named by 6 platforms and is described as having the most lenient diabetes underwriting, but at higher premiums ^[99]. Aetna and Aflac occupy the middle: moderate pricing, moderate underwriting flexibility ^[101]. .

Where the AI Platforms Agreed

Questions This Section Answers

• On which final expense carriers for people with diabetes did all AI platforms agree, and what underwriting factors did they consistently cite?

• Mutual of Omaha belongs in the shortlist. All 7 platforms named it, and no platform rated the fit below "good" ^[103].

• Transamerica is the leniency alternative. Six platforms named it, and the platforms that discussed underwriting flexibility consistently described it as more lenient than Mutual of Omaha for insulin-dependent and complicated diabetes ^[110].

• Diabetes complications drive tier placement. Platforms across entities agreed that neuropathy, retinopathy, nephropathy, amputation, coma, and insulin shock are the complications that most often push applicants from level to graded or guaranteed issue ^[113]. .

Where the AI Platforms Disagreed

Questions This Section Answers

• Where did AI platforms disagree about the best final expense carrier for people with diabetes, and what should a buyer verify because of those disagreements?

• Royal Neighbors of America's rank spread. One platform placed it first; another placed it tenth ^[123]. Kimi rated the fit "uncertain" and noted the carrier is absent from published 2026 rate comparisons ^[125].

• Trinity Life Insurance Company's verifiability. Three platforms rated the fit "good" and described a Golden Eagle product with explicit diabetes acceptance ^[126]. Three platforms rated it "uncertain" or "weak" and noted the supplied official website is a church site ^[128].

• American Amicable's leniency. DeepSeek and Kimi rated it "strong" and described frequent approval of insulin users for day-one coverage ^[131][e8:kimi:theburialinsurance.com-2026]. OpenAI, Anthropic, Grok, and Perplexity rated it "mixed" and emphasized knockout conditions ^[132].

• Mutual of Omaha's insulin treatment. Kimi described many insulin users as eligible for Level day-one coverage ^[136].

How Buyers Should Choose

Questions This Section Answers

• What should a buyer check before choosing a final expense carrier for diabetes, and which carrier fits which diabetes profile?
• Which final expense carrier for people with diabetes has the lowest published cost, and what fees apply?

Start with the diabetes profile, not the carrier. The evidence supports a decision sequence:

1. If diabetes is well controlled, non-insulin, diagnosed after age 50, with no complications: Mutual of Omaha is the consensus first quote, because it is named by all 7 platforms and described as lowest-cost for qualifying applicants ^[137].
2. If insulin is used, or diabetes is paired with COPD or heart disease: Transamerica is the consensus leniency alternative ^[139].
3. If diabetic neuropathy is present, or the applicant is overweight: Royal Neighbors of America is the standout, because platforms report neuropathy is not asked and no build chart is used ^[141].
4. If health questions cannot be answered favorably: Gerber Life Guaranteed Life Insurance or AIG/Corebridge Guaranteed Issue Whole Life are the confirmed guaranteed-acceptance paths, both with two-year graded periods [e5:official:C1]^[143].

Methodology

This index was produced from a single standardized prompt sent once to each of 7 AI platforms on 2026-09-22: openai, anthropic, deepseek, grok, perplexity, kimi, and google. The prompt asked which life insurance carriers would be recommended for a senior with diabetes seeking approximately $15,000–$25,000 of permanent final expense life insurance, with underwriting that may be reasonably favorable for well-managed or otherwise insurable diabetes.

Entities were included if named by at least two platforms during ranking discovery. The final ranking order is based on platform mentions, then average listed rank, then best listed rank. Platform mentions count only ranking-discovery mentions; they do not reflect how many platforms later completed a fit assessment.

Each qualifying entity was then researched across the same platforms, and the resulting evidence bundles were consolidated into the individual ranked sections above. Citations are platform-reported evidence, not independently verified facts. The URLs were collected from platform responses and were not independently validated by the writer stage.

Methodology Limitations

• The study used one standardized prompt sent once to each included platform. AI answers can vary by date, wording, location, account state, model, interface, browsing configuration, and the sources retrieved.
• Platform-reported research dates differ from the authoritative run date of 2026-09-22. DeepSeek reported 2026-02-14 for Mutual of Omaha and 2026-01-15 for Transamerica, AIG, Gerber Life, and Aflac; Anthropic reported 2025-01-10 for Royal Neighbors of America and 2026-01-14/2026-01-15 for Trinity Life and AIG. These are provenance metadata and do not independently prove freshness.
• Platform recommendations are market intelligence, not independent customer reviews or proof of quality.
• Company-owned sources are distinguished from independent sources where the entity evidence bundles provide that information. Several carriers' most detailed diabetes underwriting claims come from agent-facing materials, distributor guides, or quote-site summaries rather than carrier-published consumer pages.
• Official-site retrieval failed for one or more mentions for Mutual of Omaha, Royal Neighbors of America, AIG, Gerber Life, Aetna, Aflac, Trinity Life, and Foresters Financial. No failed fetch was used as a verified domain key.
• The deterministic identity audit flagged that the supplied official website for Trinity Life Insurance Company (trinitybaltimore.church) resolves to a church organization, not an insurer, and that the insurer's product information was found at a different domain. .

Final Verdict

Mutual of Omaha is the consensus leader for a senior with diabetes seeking $15,000–$25,000 of permanent final expense coverage, named by all 7 platforms studied. It is the strongest fit for well-controlled, non-insulin, later-diagnosed diabetes without complications, where its Living Promise Level Benefit offers day-one full coverage at the lowest reported simplified-issue rates. Transamerica is the strongest alternative for insulin-dependent or complicated diabetes profiles, at higher cost and with a materially worse customer-service record. Royal Neighbors of America is the standout for diabetic neuropathy and no-build-chart cases, though its rank spread across platforms is the widest in the study. Gerber Life Guaranteed Life Insurance and AIG/Corebridge serve buyers who need guaranteed acceptance, with two-year graded benefit periods as the tradeoff. No carrier's diabetes-specific acceptance rules or premiums were publicly confirmable, so every buyer should obtain a state-specific quote and written underwriting classification before committing.